Skip to content
S524Senate2023-2024 Session

Expand Hepatitis C Testing

Official title

“Expands hepatitis C screening testing”

Sponsor Gustavo RiveraSD-33+1 co-sponsorAffects Health
Status
In Senate Committee
Health
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill expands mandatory hepatitis C screening to individuals born between 1980 and 2000 in addition to previous age groups.

Why it matters

  1. Broader early detection. By including people born between 1980 and 2000, the bill aims to catch hepatitis C infections in younger adults who may not realize they’re at risk, potentially preventing complications and transmission.

  2. Public health impact. Expanded screening could identify undiagnosed cases in a population often missed under current guidelines (focused on those born 1945-1965), which could help reduce the long-term healthcare burden of untreated hepatitis C.

  3. Healthcare system readiness. The expansion requires primary care providers and hospitals to adjust protocols and resources to accommodate a significantly larger group, which may lead to increased immediate costs but could save money in the long run by averting advanced liver disease.

  4. Reducing stigma and normalizing testing. Making hepatitis C screening routine for a wider age range may help destigmatize the disease, encouraging more people to seek testing and care without fear of being singled out.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Expand Hepatitis C Testing

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Gustavo Rivera

Senator · Senate District 33

Chair, Health

1 Co-sponsor

History

  1. Referred to health
  2. Reported and committed to finance
  3. Referred to health

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

524

2023-2024 Regular Sessions

IN SENATE

January 4, 2023

Introduced by Sen. RIVERA -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to hepatitis C screening testing

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision 1 of section 2171 of the public health law, as added by chapter 425 of the laws of 2013, is amended to read as follows:

1. Every individual born between the years of nineteen hundred fortyfive and nineteen hundred sixty-five or between the years of nineteen hundred eighty and two thousand who receives health services as an inpatient in a general hospital defined in subdivision ten of section twenty-eight hundred one of this chapter or who receives primary care services in an outpatient department of such hospital or in a diagnostic and treatment center licensed under article twenty-eight of this chapter or from a physician, physician assistant or nurse practitioner providing primary care shall be offered a hepatitis C screening test or hepatitis C diagnostic test unless the health care practitioner providing such services reasonably believes that:

(a) the individual is being treated for a life threatening emergency; or

(b) the individual has previously been offered or has been the subject of a hepatitis C screening test (except that a test shall be offered if otherwise indicated); or

(c) the individual lacks capacity to consent to a hepatitis C screening test.

§ 2. This act shall take effect immediately; provided, however, that the amendments to section 2171 of the public health law made by section one of this act shall not affect the repeal of such section and shall expire and be deemed repealed therewith.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD01822-01-3

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to hepatitis C screening testing

Purpose

This bill will expand eligibility requirements for Hepatitis C screen- ing.

Summary of specific provisions

Section 1 amends section 2171 of the public health law to expand cover- age to include individuals born between the years of nineteen hundred eight and two thousand to be eligible to receive hepatitis C screening and testing from a general hospital, outpatient department, licensed diagnostic and treatment center, or directly from a physician, physi- cian's assistant or nurse practitioner.

Section 2 is the effective date.

Justification

Hepatitis C (HCV) is a viral infection known to cause liver inflamma- tion, which may lead to liver damage, cirrhosis, liver cancer, liver failure, and death. The virus can cause a short-term (acute) illness characterized by fever, nausea, abdominal pain, malaise, and jaundice; however, these acute infections often do not cause any symptoms. Nationally, the CDC estimates that 2.4 million Americans are infected with HCV, with half of the carriers unaware of their status.

According to the 2021 New York State Department of Health Hepatitis B and C Annual Report, there were 4,249 cases of Hepatitis C reported in New York State, not including New York City. The largest number of cases were seen in people between the ages of 25-39, accounting for 41.3% of the cases. The majority of HCV diagnosis among young adults is identi- fied as a direct result of the current opioid and intravenous drug use crisis. The most common causes of HCV in 2021 were injection and non-in- jection drug use, previous history of incarceration, and having close contact with a person with HCV.

Diagnostic testing is a critical tool utilized to identify the presence of disease within an individual and is proven to increase participation rates among those diagnosed with HCV in active treatment. Therefore, by virtue of the increased prevalence of opioid use and subsequent HCV diagnosis among young adults between the ages of 20-40, it is critical to mandate this population be presented with the opportunity for screen- ing and testing services, while engaged in otherwise routine medical appointments.

Legislative history

2019-2020: S7328/No Same-As

2021-2022: S2124/A9633 Zebrowski

Fiscal implications

None

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.